SCHEMBL2586754

SCHEMBL2586754

CCCCOc1nc(N)c2ccccc2n1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 8/20 0.52
TLR7 Q9NYK1 8/20 0.48
NPC1 O15118 1/20 0.48
PKM P14618 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 1/20 0.48
DCPS Q96C86 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
NPY1R P25929 1/20 0.47
NPY2R P49146 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NCF1 P14598 1/20 0.46
CYP1A1 P04798 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP1B1 Q16678 1/20 0.44
SCN9A Q15858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689003 0.92 TLR8 (0.51) TLR8NPC1PKMRAB9AKMT2A
SCHEMBL14964747 0.85 KMT2A (0.55) TLR8NPC1PKMRAB9AKMT2A
SCHEMBL3023761 0.84 TLR7 (0.50) TLR7NPC1PKMRAB9AKMT2A
Hydrochloric Acid SCHEMBL6908984 0.84 NCF1 (0.59) NPC1PKMRAB9AKMT2ADCPS
Hydrochloric Acid SCHEMBL3231113 0.83 TLR7 (0.49) TLR7NPC1PKMRAB9AKMT2A
SCHEMBL28036770 0.79 DCPS (0.49) NPC1PKMRAB9AKMT2ADCPS
SCHEMBL30689007 0.77 ACP1 (0.55) ALDH1A1
SCHEMBL6380647 0.76 TLR7 (0.45) TLR7NPC1PKMRAB9AKMT2A
SCHEMBL148103 0.76 DCPS (0.57) TLR8NPC1PKMRAB9AKMT2A
SCHEMBL16836380 0.75 NCF1 (0.76) TLR8NCF1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2566480-A2 METHODS AND COMPOSITIONS FOR INHIBITION OF THE TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE California Institute of Technology (US) 2013-03-13 EP disclosed
WO-2011140527-A2 METHODS AND COMPOSITIONS FOR INHIBITION OF THE TRANSITIONAL ENDOPLASMIC RETICULUM ATPASE CALIFORNIA INSTITUTE OF TECHNOLOGY AND THE UNIVERSITY OF KANSAS (US) 2011-11-10 WO disclosed